Valencia, Spain

Akaitz Dorronsoro Gonzàlez


Average Co-Inventor Count = 21.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akaitz Dorronsoro Gonzàlez: Innovator in Cardiotoxicity Prediction

Introduction

Akaitz Dorronsoro Gonzàlez is a notable inventor based in Valencia, Spain. He has made significant contributions to the field of medical research, particularly in predicting cardiotoxicity risk in cancer patients undergoing anthracyclines chemotherapy. His innovative approach has the potential to improve patient outcomes and enhance treatment safety.

Latest Patents

Akaitz holds a patent for a groundbreaking invention titled "Predicting cardiotoxicity risk in cancer patients receiving anthracyclines chemotherapy." This invention outlines an in vitro method for assessing the risk of cardiotoxicity by determining the expression levels of a combination of 10 circulating miRNAs in biological samples from patients. The identified miRNAs include miRNA 16-5p, miRNA 22-3p, miRNA 30b-5p/30c-5p, miRNA 92b-3p, miRNA 148a-3p, miRNA-150-5p, miRNA 192-5p, miRNA 215-5p, miRNA 486-3p/486-5p, and miRNA-4732-3p. This set of miRNAs serves as a biomarker for predicting cardiotoxicity risk, and the invention also proposes a method for preventing cardiotoxicity by modulating the expression levels of these miRNAs.

Career Highlights

Throughout his career, Akaitz has worked with esteemed institutions such as the Fundación para la Investigación del Hospital Universitario La Fe de la Comunidad Valenciana and Maastricht University. His work has focused on advancing medical research and developing innovative solutions to complex health issues.

Collaborations

Akaitz has collaborated with notable colleagues, including David Hervàs Marin and Ana Santaballa Beltràn. These partnerships have contributed to the success of his research and the development of his patent.

Conclusion

Akaitz Dorronsoro Gonzàlez is a pioneering inventor whose work in predicting cardiotoxicity risk represents a significant advancement in cancer treatment. His innovative methods and collaborations highlight the importance of research in improving patient care and safety.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…